Rocuronium ( DrugBank: Rocuronium )


2 diseases
IDDisease name (Link within this page)Number of trials
70Spinal stenosis1
296Biliary atresia1

70. Spinal stenosis


Clinical trials : 95 Drugs : 169 - (DrugBank : 61) / Drug target genes : 68 - Drug target pathways : 90
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05619848
(ClinicalTrials.gov)
October 25, 20229/11/2022Effect of Paravertebral Muscle Fat Infiltration on Rocuronium Use in Lumbar SurgeryEffect of Paravertebral Muscle Fat Infiltration on Rocuronium Use in Lumbar SurgerySpinal Stenosis LumbarDrug: Rocuronium BromideZheng GuoNULLCompleted18 Years65 YearsAll87Early Phase 1China

296. Biliary atresia


Clinical trials : 71 Drugs : 70 - (DrugBank : 39) / Drug target genes : 35 - Drug target pathways : 60
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1ChiCTR-OOC-16008707
2016-06-012016-06-22Study on pharmacodynamics of continuous infusion of rocuronium during transplantation of living donor liver transplantation for infantsStudy on pharmacodynamics of continuous infusion of rocuronium during transplantation of living donor liver transplantation for infants congenital biliary atresiaobstructive jaundice group:continuous infusion of rocuronium;after Kasai portoenterostomy group :continuous infusion of rocuronium;Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong UniversityNULLRecruitingBothobstructive jaundice group:15;after Kasai portoenterostomy group :15;China